Interestingly, ABZ did not show distinct anti-tumor effects in ovarian cancers, but reduced ascites formation by inhibiting VEGF expression, and thus, eventually inhibiting angiogenesis [41,45,46]. The gene discussed is VEGFA; the disease is ovarian carcinoma.